COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 42(2022), 4 vom: 11. Mai, Seite 728-731 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ponsford, Mark J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.06.2022 Date Revised 18.08.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10875-022-01223-7 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM336820992 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM336820992 | ||
| 003 | DE-627 | ||
| 005 | 20231225233018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-022-01223-7 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1122.xml |
| 035 | |a (DE-627)NLM336820992 | ||
| 035 | |a (NLM)35149962 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ponsford, Mark J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2022 | ||
| 500 | |a Date Revised 18.08.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Evans, Kimberly |e verfasserin |4 aut | |
| 700 | 1 | |a Carne, Emily M |e verfasserin |4 aut | |
| 700 | 1 | |a Jolles, Stephen |e verfasserin |4 aut | |
| 700 | 0 | |a Immunodeficiency Centre for Wales and Division of Population Medicine |e verfasserin |4 aut | |
| 700 | 1 | |a Bramhall, Kathryn |e investigator |4 oth | |
| 700 | 1 | |a Grant, Leanne |e investigator |4 oth | |
| 700 | 1 | |a McGuire, Frances |e investigator |4 oth | |
| 700 | 1 | |a Matthews, Anthony |e investigator |4 oth | |
| 700 | 1 | |a Bradley, Rachel |e investigator |4 oth | |
| 700 | 1 | |a Wijetilleka, Sonali |e investigator |4 oth | |
| 700 | 1 | |a Pritchard, Alison |e investigator |4 oth | |
| 700 | 1 | |a Price, Colin R |e investigator |4 oth | |
| 700 | 1 | |a Farewell, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Cousins, Richard |e investigator |4 oth | |
| 700 | 1 | |a El-Shanawany, Tariq |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 42(2022), 4 vom: 11. Mai, Seite 728-731 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:4 |g day:11 |g month:05 |g pages:728-731 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-022-01223-7 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 4 |b 11 |c 05 |h 728-731 | ||